Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Oncolytic virus driven T-cell-based combination immunotherapy platform for colorectal cancer.
Front Immunol. 2022 Nov 3;13:1029269. doi: 10.3389/fimmu.2022.1029269. eCollection 2022.
Front Immunol. 2022.
PMID: 36405739
Free PMC article.
Engineering Rapalog-Inducible Genetic Switches Based on Split-T7 Polymerase to Regulate Oncolytic Virus-Driven Production of Tumour-Localized IL-12 for Anti-Cancer Immunotherapy.
Martin NT, Crupi MJF, Taha Z, Poutou J, Whelan JT, Vallati S, Petryk J, Marius R, Austin B, Azad T, Boulanger M, Burgess T, Sanders I, Victoor C, Dickinson BC, Diallo JS, Ilkow CS, Bell JC.
Martin NT, et al. Among authors: vallati s.
Pharmaceuticals (Basel). 2023 May 7;16(5):709. doi: 10.3390/ph16050709.
Pharmaceuticals (Basel). 2023.
PMID: 37242495
Free PMC article.
Item in Clipboard
Cite
Cite